Highlights and Quick Summary
- Annual 3Y Revenue Growth (per Share) for 2021 was 0.0% (a NaN% decrease from previous year)
- Annual 3Y Revenue Growth (per Share) for 2020 was 0.0% (a NaN% decrease from previous year)
- Annual 3Y Revenue Growth (per Share) for 2019 was 0.0% (a NaN% decrease from previous year)
Visit stockrow.com/BBLG
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical 3Y Revenue Growth (per Share) of Bone Biologics Corp.
Most recent 3Y Revenue Growth (per Share)of BBLG including historical data for past 10 years.Interactive Chart of 3Y Revenue Growth (per Share) of Bone Biologics Corp.
Bone Biologics Corp. 3Y Revenue Growth (per Share) for the past 10 Years (both Annual and Quarterly)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2021 | – | – | – | – | 0.0% |
| 2020 | – | – | – | – | 0.0% |
| 2019 | – | – | – | – | 0.0% |
| 2018 | – | – | – | – | 0.0% |
| 2017 | – | – | – | – | 0.0% |
| 2016 | – | – | – | – | 0.0% |
Business Profile of Bone Biologics Corp.
Sector: Healthcare
Industry: Medical Devices